Zweig-DiMenna Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-3,800	Closed	-$255K	–	245
2014 Q1	$255K	Buy	+3,800	New	+$255K	0.02%	154